Last checked at 28 Sep 2012 15:30
Tissue Regenix
Notification of Results and Technology Day
York, 28 September 2012 - Tissue Regenix, the regenerative medical devices company, will be announcing its unaudited interim results for the six months ended 31 July 2012 on Thursday 4 October.
A Technology Day will be held at 10am on Friday 5 October at the offices of Newgate Communications, Fifth Floor, 33 King William Street, London, EC4R 9AS.
Enquiries:
Newgate Communications 020 7680 6550
Alistair Kellie/Andrew Adie/Martin Greig
Peel Hunt LLP 020 7418 8900
James Steel/ Vijay Barathan
Notes to Editors:
Tissue Regenix, (AIM:TRX) the regenerative medical devices company , was incorporated in May 2006 to commercialise the academic research of Professor Eileen Ingham and Professor John Fisher from the University of Leeds in the field of tissue decellularisation. Its dCELL® technology comprises a patented process which removes cells and other component from human and animal tissue, allowing it to be used without anti-rejection drugs to replace worn out or diseased body parts.